COVID-19 among University of Otago students living in North Dunedin households in the first half of 2022: was the prevalence underestimated?

AIMS: To estimate the prevalence of COVID-19 among occupants of North Dunedin student flats between Flat Orientation Week (Flo-Week, week starting 14 February 2022) and the end of Semester 1 (week starting 30 May 2022); to investigate the potential under-reporting of cases to the University of Otago and under-recording of positive rapid antigen test (RAT) results in My Covid Record; to explore the COVID-related experiences of students during the above period. METHODS: Randomly selected households in the North Dunedin area were visited at the end of Semester 1 and oral consent was sought for a short interview comprising closed- and open-ended questions. Households were eligible for inclusion if at least one resident was a University of Otago student. RESULTS: One hundred and thirty-five (96.4%) of 140 eligible households participated, and in 94.1% of these households at least one resident tested positive for COVID-19 between the start of Flo-Week and the date of the interview (a mean period of 109 days [standard deviation 3.6]). In total, 73.6% of the occupants in the participating households tested positive. Of the cases who were University of Otago students, 60.4% reported their positive status to the University. Of all cases diagnosed via a RAT, 66.9% uploaded their result to My Covid Record. Students reported various academic, financial and mental health stresses associated with the general COVID-19 situation during the study period. CONCLUSIONS: These findings suggest that the number of COVID-19 cases reported to the University of Otago between Flo-Week and the end of Semester 1 was a substantial underestimate of the true number, as was the number of cases recorded in My Covid Record. The findings also highlight the considerable impact that COVID-19 had on students during Semester 1.

Human Papillomavirus E6/E7 Expression in Preeclampsia-Affected Placentae.

Whether HPV is causative of pregnancy complications is uncertain. E6 and E7 affect functions underling preeclampsia (PET) in cultured trophoblasts, but whether E6 and E7 is produced in the placenta is uncertain. Here, we investigated whether E6/E7 was expressed in the placentae from pregnancies with PET, other pregnancy complications (fetal growth restriction (FGR) and diabetes mellitus), and uncomplicated pregnancies. Placental tissues collected from two geographical locations were subjected to RNAscope analyses of high- and low- risk E6/E7, and individual HPV types identified using an HPV array. High-risk E6/E7 expression was increased in both PET cohorts, (81% and 86% of patients positive for high-risk HPV DNA compared to 13% of control patients). Various HPV types were identified. Although HPV 18 was the most frequent in all cohorts, the majority of individuals had multiple HPV types (55% of the PET compared to 25% of the control cohort). Further evidence that E6 and E7 is present early when placental pathology underlying preeclampsia is established, is provided with the finding of high-risk E6/E7 in the first-trimester placenta anchoring trophoblast. In conclusion, E6/E7 expression and multiple HPV types were frequent in placentae from preeclampsia-complicated pregnancies.